Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease

Neurology: Genetics

Volumn 2, Issue 1, 2016, Pages

  Kohli, Martin A ^a   Cukier, Holly N ^a   Hamilton Nelson, Kara L ^a   Rolati, Sophie ^a   Kunkle, Brian W ^a   Whitehead, Patrice L ^a   Züchner, Stephan L ^a   Farrer, Lindsay A ^b   Martin, Eden R ^a   Beecham, Gary W ^a   Haines, Jonathan L ^c   Vance, Jeffery M ^a   Cuccaro, Michael L ^a   Gilbert, John R ^a   Schellenberg, Gerard D ^d   Carney, Regina M ^a   Pericak Vance, Margaret A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; EXTENDED FAMILY; GENE SEGREGATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; TETRATRICOPEPTIDE REPEAT; TETRATRICOPEPTIDE REPEAT DOMAIN 3;

EID: 84994521669     PISSN: None     EISSN: 23767839     Source Type: Journal    
DOI: 10.1212/NXG.0000000000000041     Document Type: Article

References (40)

1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009;11: 111-128.
2. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer s disease. Nature 1991; 349:704-706.
3. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer s disease. Nature 1995;375:754-760.
4. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer s disease type 3 gene. Nature 1995;376:775-778.
5. Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006;63:168-174.
6. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
7. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer s disease in late onset families. Science 1993; 261:921-923.
8. Pericak-Vance MA, Haines JL. Genetic susceptibility to Alzheimer disease. Trends Genet 1995;11:504-508.
9. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-Analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
10. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Metaanalysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer s disease. Nat Genet 2013;45:1452-1458.
11. Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer s disease. N Engl J Med 2013;368:107-116.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer s disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease. Neurology 1984;34:939-944.
13. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
14. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997;278:1237-1241.
15. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754-1760.
16. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-1303.
17. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011;43:491-498.
18. A1000 Genomes Project Consortium, Abecasis GR, Altshuler D, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073.
19. Tennessen JA, Bigham AW, O Connor TD, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012;337:64-69.
20. Cooper GM, Stone EA, Asimenos G, et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005;15:901-913.
21. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005;15:1034-1050.
22. Chun S, Fay JC. Identification of deleterious mutations within three human genomes. Genome Res 2009;19:1553-1561.
23. Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 2011;39:e118.
24. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010;7:575-576.
25. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using Poly- Phen-2. Curr Protoc Hum Genet 2013. Chapter 7: Unit 7.20.
26. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012;7:e46688.
27. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
28. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007;29: 125-132.
29. Kim SY, Lee JH, Huh JW, et al. Cigarette smoke induces Akt protein degradation by the ubiquitin-proteasome system. J Biol Chem 2011;286:31932-31943.
30. Suizu F, Hiramuki Y, Okumura F, et al. The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Dev Cell 2009;17:800-810.
31. Berto G, Camera P, Fusco C, et al. The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and citron kinase. J Cell Sci 2007;120:1859-1867.
32. Bamburg JR, Bloom GS. Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 2009;66:635-649.
33. Eki T, Abe M, Naitou M, et al. Cloning and characterization of novel gene, DCRR1, expressed from Down s syndrome critical region of human chromosome 21q22. 2. DNA Seq 1997;7:153-164.
34. Behl C. Apoptosis and Alzheimer s disease. J Neural Transm 2000;107:1325-1344.
35. Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer s disease. J Neurosci 2001; 21:3017-3023.
36. Chaturvedi RK, Flint Beal M. Mitochondrial diseases of the brain. Free Radic Biol Med 2013;63:1-29.
37. Arendt T, Bruckner MK. Linking cell-cycle dysfunction in Alzheimer s disease to a failure of synaptic plasticity. Biochim Biophys Acta 2007;1772:413-421.
38. Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT. The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol Neurodegener 2009;4:14.
39. Caccamo A, Magrì A, Medina DX, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer s disease and other tauopathies. Aging Cell 2013; 12:370-380.
40. Ohira M, Ootsuyama A, Suzuki E, et al. Identification of a novel human gene containing the tetratricopeptide repeat domain from the Down syndrome region of chromosome 21. DNA Res 1996;3:9-16.